|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-10-29
|
|
pubmed:abstractText |
Although reversible perfusion defects, perfusion-metabolism mismatch and match patterns are important for differentiating viable from nonviable myocardium, the frequency of these scintigraphic patterns has not been reported. The study objective was to establish the incidence of these scintigraphic patterns to estimate the clinical need for metabolic positron emission tomography for evaluating tissue viability in patients with prior myocardial infarction (MI).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1071-3581
|
|
pubmed:author |
pubmed-author:BrunkenR CRC,
pubmed-author:ChenE QEQ,
pubmed-author:CookS ASA,
pubmed-author:HOR WRW,
pubmed-author:KhandekarSS,
pubmed-author:LAMBT WTW,
pubmed-author:MacIntyreW JWJ,
pubmed-author:MarwickT HTH,
pubmed-author:NeumannD RDR,
pubmed-author:SahaG BGB,
pubmed-author:UnderwoodD ADA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
96-104
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8799234-Adult,
pubmed-meshheading:8799234-Aged,
pubmed-meshheading:8799234-Aged, 80 and over,
pubmed-meshheading:8799234-Deoxyglucose,
pubmed-meshheading:8799234-Female,
pubmed-meshheading:8799234-Fluorine Radioisotopes,
pubmed-meshheading:8799234-Fluorodeoxyglucose F18,
pubmed-meshheading:8799234-Heart,
pubmed-meshheading:8799234-Humans,
pubmed-meshheading:8799234-Male,
pubmed-meshheading:8799234-Middle Aged,
pubmed-meshheading:8799234-Myocardial Infarction,
pubmed-meshheading:8799234-Rubidium Radioisotopes,
pubmed-meshheading:8799234-Tissue Survival,
pubmed-meshheading:8799234-Tomography, Emission-Computed,
pubmed-meshheading:8799234-Ventricular Dysfunction, Left
|
|
pubmed:articleTitle |
The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, Cleveland Clinic Foundation, OH 44195-5074, USA.
|
|
pubmed:publicationType |
Journal Article
|
